Efficacy, safety, and tolerability of ipragliflozin in Asian patients with type 2 diabetes mellitus and inadequate glycemic control with metformin: Results of a phase 3 randomized, placebo‐controlled, double‐blind, multicenter trial

AIMS/INTRODUCTION: To determine the efficacy and safety of ipragliflozin in combination with metformin in Asian patients with type 2 diabetes mellitus. MATERIALS AND METHODS: This phase 3, multicenter, placebo‐controlled, double‐blind, parallel‐group study was carried out at 18 sites in Korea and 12...

Descripción completa

Detalles Bibliográficos
Autores principales: Lu, Chieh‐Hsiang, Min, Kyung Wan, Chuang, Lee‐Ming, Kokubo, Satoshi, Yoshida, Satoshi, Cha, Bong‐Soo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2015
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4847891/
https://www.ncbi.nlm.nih.gov/pubmed/27330723
http://dx.doi.org/10.1111/jdi.12422

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4847891/
https://www.ncbi.nlm.nih.gov/pubmed/27330723
http://dx.doi.org/10.1111/jdi.12422

Ejemplares similares